Phase II Study of Temozolomide in Relapsed or Refractory High-Risk Neuroblastoma: A Joint Société Française des Cancers de l’Enfant and United Kingdom Children Cancer Study Group–New Agents Group Study - Concepedia

Concepedia

Publication | Open Access

Phase II Study of Temozolomide in Relapsed or Refractory High-Risk Neuroblastoma: A Joint Société Française des Cancers de l’Enfant and United Kingdom Children Cancer Study Group–New Agents Group Study

DOI Full Paper Access

64

Citations

35

References

2006

Year

Hervé Rubie, Julia Chisholm, Anne Sophie Defachelles, Bruce Morland, Caroline Munzer, Dominique Valteau‐Couanet, Véronique Mosseri, Christophe Bergeron, Clare E. Weston, Carole Coze,

Journal of Clinical Oncology

Abstract

Temozolomide shows activity in heavily pretreated patients with NB, and deserves further evaluation in combination with another drug.

References

	Year	Citations

Page 1